Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration-Reference-Cited by-同舟云学术

Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration

Published:2023-07-19 Issue:30 Volume:15 Page:35895-35905
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Xiao Lucheng¹²,Yu Weili¹,Shen Lijuan¹,Yan Wenying¹²,Qi Jinming¹,Hu Tao¹^ORCID

Affiliation:

1. State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 1 Bei-Er-Jie Street, Haidian District, Beijing 100190, China

2. University of Chinese Academy of Sciences, 19 Yuquan Road, Shijingshan District, Beijing 100049, China

Funder

National Key Research and Development Program of China

Beijing Municipal Natural Science Foundation

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c05456

Reference51 articles.

1. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

2. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents

3. Functional consequences of SARS-CoV-2 infection in pregnant women, fetoplacental unit, and neonate

4. Characteristics of SARS-CoV-2 exhaled by COVID-19 patients

5. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc-empowered exosomes with superior epithelial layer transmission and lung distribution ability for pulmonary vaccination;Bioactive Materials;2024-12

2. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

3. Self-Assembling Sulfated Lactobacillus Exopolysaccharide Nanoparticles as Adjuvants for SARS-CoV-2 Subunit Vaccine Elicit Potent Humoral and Cellular Immune Responses;ACS Applied Materials & Interfaces;2024-04-02

4. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses;Antiviral Research;2024-03

5. Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5;Vaccines;2023-12-28